# Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

> **NCT00651274** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 144 (actual)

## Conditions studied

- Atherosclerosis
- Hypercholesterolemia
- Coronary Heart Disease

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00651274
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04-01
- **Primary completion:** 2004-08-01
- **Final completion:** 2004-08-01
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651274, "Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00651274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*